HIZOF(HIZOF)
HIZOF
No analyst ratings available
No analyst price targets available for HIZOF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $677.42B | $716.18B | $756.82B | $805.53B | $850.57B |
| Low | $656.53B | $702.27B | $737.91B | $785.41B | $829.32B |
| High | $698.32B | $730.09B | $775.73B | $825.66B | $871.82B |
| EBITDA Avg | $48.32B | $47.06B | $55.83B | $56.84B | $62.72B |
| Low | $47.39B | $46.18B | $54.69B | $55.69B | $61.40B |
| High | $49.25B | $47.93B | $56.98B | $58.00B | $64.04B |
| EBIT Avg | $29.99B | $28.37B | $36.64B | $36.96B | $42.04B |
| Low | $29.06B | $27.50B | $35.49B | $35.81B | $40.72B |
| High | $30.92B | $29.25B | $37.78B | $38.12B | $43.36B |
| Net Income Avg | $24.24B | $22.87B | $29.86B | $30.13B | $34.42B |
| Low | $23.45B | $22.13B | $28.89B | $29.15B | $33.31B |
| High | $25.02B | $23.61B | $30.83B | $31.11B | $35.54B |
| EPS Avg | $144.07 | $135.94 | $177.47 | $179.11 | $204.63 |
| Low | $139.39 | $131.52 | $171.71 | $173.30 | $197.98 |
| High | $148.75 | $140.35 | $183.24 | $184.93 | $211.27 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $183.57B | $170.94B | $185.73B |
| Low | $183.57B | $170.94B | $185.73B |
| High | $183.57B | $170.94B | $185.73B |
| EBITDA Avg | $13.54B | $12.13B | $19.59B |
| Low | $13.54B | $12.13B | $19.59B |
| High | $13.54B | $12.13B | $19.59B |
| EBIT Avg | $9.10B | $7.68B | $15.10B |
| Low | $9.10B | $7.68B | $15.10B |
| High | $9.10B | $7.68B | $15.10B |
| Net Income Avg | $7.07B | $5.86B | $12.14B |
| Low | $7.07B | $5.86B | $12.14B |
| High | $7.07B | $5.86B | $12.14B |
| EPS Avg | $42.01 | $34.84 | $72.14 |
| Low | $42.01 | $34.84 | $72.14 |
| High | $42.01 | $34.84 | $72.14 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |